SSRI use tied to small increase in diabetes risk among children and adolescents
05 Oct 2020
byDr Margaret Shi
Children and adolescents initiating selective serotonin reuptake inhibitor (SSRI) treatment may have a small increase in risk of developing type 2 diabetes mellitus (T2DM), particularly among publicly insured patients, results of a recent study have shown.
